Literature DB >> 32409510

Description of a multidisciplinary model of care in a French cohort of adult patients with tuberous sclerosis complex.

Pierre Pfirmann1,2, Jerome Aupy3, Eva Jambon4, Laetitia Idier5,6, Mathilde Prezelin-Reydit6,7, Marine Fermis8, Raphael Devillard2,8, Nicolas Grenier4, Christian Combe5,2, Claire Rigothier5,2.   

Abstract

BACKGROUND: Tuberous sclerosis complex (TSC) is a rare autosomal dominant genetic disorder. Due to the various manifestations of TSC and their potential complications, a multidisciplinary care approach is recommended by consensus guidelines.
OBJECTIVES: Our study aimed to give a complete description of our TSC adult cohort and to evaluate the multidisciplinary and interdisciplinary management model.
METHODS: Data on each adult patient diagnosed with TSC, including disease manifestations, interventions and outcomes, were collected at baseline and updated annually. A multidisciplinary TSC approach with all the recommended explorations was carried out annually.
RESULTS: 90 patients were enrolled in Centre Hospitalier Universitaire de Bordeaux, between January 2000 and September 2018. Median age of patients at inclusion was 37 years (range, 27-47) and 20 years old at diagnosis of TSC. Regarding the occurrence of TSC manifestations, 97% of the patients had cutaneous lesions, 89% had neurological manifestations, 83% had renal manifestations and 100% had dental lesions with pits. More than half the patients had sclerotic bone lesions (68%), TSC-associated neuropsychiatric disorders (64%) and lymphangioleiomyomatosis (59%). A TSC multidisciplinary approach was developed including a global follow-up and an evaluation of TSC targeting organs, according to the recommendations. A satisfaction survey revealed global and entire satisfaction of patients with TSC.
CONCLUSION: We obtained an accurate description of a cohort of adult patients with TSC. Our multidisciplinary approach model allowed us to provide optimal management of patients with TSC with a high level of patient satisfaction. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  mTOR inhibitor; quality of life; registry; renal angiomyolipoma; tuberous sclerosis complex

Year:  2020        PMID: 32409510     DOI: 10.1136/jmedgenet-2019-106607

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  2 in total

1.  Clinical, genetic and quality-of-life study of a cohort of adult patients with tuberous sclerosis.

Authors:  Elena Cristina De Sautu De Borbón; Juan Manuel Guerra Vales; Carlos Lumbreras Bermejo; Felix Guerrero Ramos; María José Buj Padilla; Jesús González de la Aleja; Montserrat Morales Conejo
Journal:  Orphanet J Rare Dis       Date:  2021-05-31       Impact factor: 4.123

2.  Radiological Characteristics of Renal Lesions During Tuberous Sclerosis Complex: Impact of Mechanistic Target of Rapamycin Inhibitor Treatment.

Authors:  Pierre Pfirmann; Eva Jambon; Jérome Aupy; Jean-Christophe Bernhard; Hugo Bakis; Christian Combe; Nicolas Grenier; Claire Rigothier
Journal:  Kidney Int Rep       Date:  2022-08-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.